Gene · 3918
Papers2,268
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,268
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prognostic effect of lncRNA BBOX1-AS1 in malignancies: a meta-analysis. | Front Genet | 2023 | 37636267 | PubTator, text mining | PubMed |
| The Role and Applications of Exosomes in Gynecological Cancer: A Review. | Cell Transplant | 2023 | 37632354 | PubTator, text mining | PubMed |
| Advancing Breast Cancer Heterogeneity Analysis: Insights from Genomics, Transcriptomics and Proteomics at Bulk and Single-Cell Levels. | Cancers (Basel) | 2023 | 37627192 | PubTator, text mining | PubMed |
| Pancreatic Cancer: From Genetic Mechanisms to Translational Challenges. | Cancers (Basel) | 2023 | 37627084 | PubTator, text mining | PubMed |
| The Activation of the LIMK/Cofilin Signaling Pathway via Extracellular Matrix-Integrin Interactions Is Critical for the Generation of Mature and Vascularized Cardiac Organoids. | Cells | 2023 | 37626839 | PubTator, text mining | PubMed |
| Stochastic epithelial-mesenchymal transitions diversify non-cancerous lung cell behaviours. | Transl Oncol | 2023 | 37611490 | PubTator, text mining | PubMed |
| Advances in transcriptomics and proteomics in differentiated thyroid cancer: An updated perspective (Review). | Oncol Lett | 2023 | 37600346 | PubTator, text mining | PubMed |
| Spatial transcriptomics reveals distinct and conserved tumor core and edge architectures that predict survival and targeted therapy response. | Nat Commun | 2023 | 37596273 | PubTator, text mining | PubMed |
| Characterization of the skin keloid microenvironment. | Cell Commun Signal | 2023 | 37587491 | PubTator, text mining | PubMed |
| Novel human lymph node-derived matrix supports the adhesion of metastatic oral carcinoma cells. | BMC Cancer | 2023 | 37580662 | PubTator, text mining | PubMed |
| Potassium and Cesium Fluorinated β-Diketonates: Effect of a Cation and Terminal Substituent on Structural and Thermal Properties. | Molecules | 2023 | 37570856 | PubTator, text mining | PubMed |
| Dysregulated Signalling Pathways Driving Anticancer Drug Resistance. | Int J Mol Sci | 2023 | 37569598 | PubTator, text mining | PubMed |
| Comprehensive bioinformatics analysis and experimental validation: An anoikis-related gene prognostic model for targeted drug development in head and neck squamous cell carcinoma. | Oncol Res | 2023 | 37547764 | PubTator, text mining | PubMed |
| Unraveling the Relevance of Tissue-Specific Decellularized Extracellular Matrix Hydrogels for Vocal Fold Regenerative Biomaterials: A Comprehensive Proteomic and In Vitro Study. | Adv Nanobiomed Res | 2023 | 37547672 | PubTator, text mining | PubMed |
| Identification and comprehensive analysis of epithelial-mesenchymal transition related target genes of miR-222-3p in breast cancer. | Front Oncol | 2023 | 37546414 | PubTator, text mining | PubMed |
| LAMC2 promotes EGFR cell membrane localization and acts as a novel biomarker for tyrosine kinase inhibitors (TKIs) sensitivity in lung cancer. | Cancer Gene Ther | 2023 | 37542131 | PubTator, text mining | PubMed |
| Evaluation of Clinical and Oral Findings in Patients with Epidermolysis bullosa. | Medicina (Kaunas) | 2023 | 37511997 | PubTator, text mining | PubMed |
| RNA-Based Liquid Biopsy in Head and Neck Cancer. | Cells | 2023 | 37508579 | PubTator, text mining | PubMed |
| Sequence variants contributing to dysregulated inflammatory responses across keratoconic cone surface in adolescent patients with keratoconus. | Front Immunol | 2023 | 37483635 | PubTator, text mining | PubMed |
| The promising application of cell-cell interaction analysis in cancer from single-cell and spatial transcriptomics. | Semin Cancer Biol | 2023 | 37454878 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3918/papers?page=12